Over the past decade ARTIS has continued to focus its energies and resources on the growing opportunity to deliver frontier technologies, specifically AI, to the worlds of healthcare and biology. As investors who care deeply about both value creation and societal impact, it’s gratifying when founders we supported early in their development achieve significant milestones toward positively impacting patient outcomes. That’s especially true with today’s news of Rad AI’s $50M Series B, led by Khosla Ventures. 

Since ARTIS led their $25M Series A in 2021, Rad AI has quickly established itself as a leading world-class example of how AI can drive significant provider productivity in healthcare, and improve the lives of patients everywhere. Since our initial investment, the company has become the fastest-growing radiologist-led AI company within healthcare, with more than one-third of US health systems and 9 of the 10 largest US radiology practices leveraging their generative AI models, saving physicians hours daily.

The company pioneered one of the first commercial generative AI products in healthcare, which automatically generates parts of the radiology report customized to the radiologist’s language and style; radiologists spend 75% of their time dictating reports based on what they see on medical images, often creating reports for more than 100 patients each day. The company’s AI models streamline repetitive tasks such as physician dictation and follow-up care management, delivering marked time savings, alleviating burnout, and giving physicians more time to focus on patient care. 

Their latest innovation, Rad AI Reporting, is now the leading AI-enabled solution for radiology reporting workflow. In addition, Rad AI Continuity, its patient follow-up solution, is currently being adopted by many of the largest health systems in the country. Rad AI’s products now provide a significant positive impact for nearly 50 million patients each year and is one of the most widely adopted generative AI solutions in healthcare. 

They have deservingly received numerous and significant industry recognition and accolades, including being recognized as one of the most promising healthcare AI companies by CB Insights (Digital Health 50, AI 100) and AuntMinnie (Best New Radiology Software of 2023, Best New Radiology Vendor of 2021).

This latest funding and support by Khosla Ventures further establishes Rad AI's credibility in the generative AI space and expands the team's ability to become the indisputable leader across the healthcare AI market. We’re excited to welcome Vinod and Khosla Ventures to support Rad AI’s next stage of growth. 

Congratulations to Doktor Gurson, Dr. Jeff Chang, and the Rad AI team on the exciting road ahead! 

‍

Learn more about Rad AI at www.radai.com or on Twitter @radai.